Industry: Pharma & Healthcare
Published Date: 2026-01-04
Pages: 93 Pages
Report ld: 5556978
Request Sample
Customized Report
Metronidazole Market Size(US$)

CAGR 2026-2032
-0.46%
Market Size,2032
USD 108
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Global Metronidazole key players include CordenPharma Farchemia, Tongji Pharmaceutical, Aarti Drugs, Manav Drugs, etc.
China is the largest market, with a share about 90%, followed by India, and Europe, both have a share over 10 percent.
In terms of product, Glyoxal Process is the largest segment, with a share over 85%. And in terms of application, the largest application is Metronidazole Tablets, followed by Metronidazole Capsule, Metronidazole Injection, etc.
The global Metronidazole market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Metronidazole sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Metronidazole manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Metronidazole product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Metronidazole value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Metronidazole Product Scope
1.2 Metronidazole by Type
1.2.1 Global Metronidazole Sales by Type (2021, 2025 & 2032)
1.2.2 Glyoxal Process
1.2.3 Ethidene Diamine Process
1.2.4 Others
1.3 Metronidazole by Application
1.3.1 Global Metronidazole Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Metronidazole Tablets
1.3.3 Metronidazole Capsule
1.3.4 Metronidazole Injection
1.3.5 Others
1.4 Global Metronidazole Market Estimates and Forecasts (2021-2032)
1.4.1 Global Metronidazole Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Metronidazole Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Metronidazole Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Metronidazole Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Metronidazole Historical Market Scenario by Region (2021-2026)
2.2.1 Global Metronidazole Sales Market Share by Region (2021-2026)
2.2.2 Global Metronidazole Revenue Market Share by Region (2021-2026)
2.3 Global Metronidazole Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Metronidazole Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Metronidazole Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Metronidazole Market Size and Prospects (2021-2032)
2.4.2 Europe Metronidazole Market Size and Prospects (2021-2032)
2.4.3 China Metronidazole Market Size and Prospects (2021-2032)
2.4.4 Japan Metronidazole Market Size and Prospects (2021-2032)
2.4.5 India Metronidazole Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Metronidazole Historical Market Review by Type (2021-2026)
3.1.1 Global Metronidazole Sales by Type (2021-2026)
3.1.2 Global Metronidazole Revenue by Type (2021-2026)
3.1.3 Global Metronidazole Average Price by Type (2021-2026)
3.2 Global Metronidazole Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Metronidazole Sales Forecast by Type (2027-2032)
3.2.2 Global Metronidazole Revenue Forecast by Type (2027-2032)
3.2.3 Global Metronidazole Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Metronidazole
4 Global Market Size by Application
4.1 Global Metronidazole Historical Market Review by Application (2021-2026)
4.1.1 Global Metronidazole Sales by Application (2021-2026)
4.1.2 Global Metronidazole Revenue by Application (2021-2026)
4.1.3 Global Metronidazole Average Price by Application (2021-2026)
4.2 Global Metronidazole Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Metronidazole Sales Forecast by Application (2027-2032)
4.2.2 Global Metronidazole Revenue Forecast by Application (2027-2032)
4.2.3 Global Metronidazole Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Metronidazole Applications
5 Competition Landscape by Players
5.1 Global Metronidazole Sales by Player (2021-2026)
5.2 Global Top Metronidazole Players by Revenue (2021-2026)
5.3 Global Metronidazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Metronidazole revenue as of 2025
5.4 Global Metronidazole Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Metronidazole, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Metronidazole, Product Type & Application
5.7 Global Key Manufacturers of Metronidazole, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Metronidazole Sales by Company
6.1.1.1 North America Metronidazole Sales by Company (2021-2026)
6.1.1.2 North America Metronidazole Revenue by Company (2021-2026)
6.1.2 North America Metronidazole Sales Breakdown by Type (2021-2026)
6.1.3 North America Metronidazole Sales Breakdown by Application (2021-2026)
6.1.4 North America Metronidazole Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Metronidazole Sales by Company
6.2.1.1 Europe Metronidazole Sales by Company (2021-2026)
6.2.1.2 Europe Metronidazole Revenue by Company (2021-2026)
6.2.2 Europe Metronidazole Sales Breakdown by Type (2021-2026)
6.2.3 Europe Metronidazole Sales Breakdown by Application (2021-2026)
6.2.4 Europe Metronidazole Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Metronidazole Sales by Company
6.3.1.1 China Metronidazole Sales by Company (2021-2026)
6.3.1.2 China Metronidazole Revenue by Company (2021-2026)
6.3.2 China Metronidazole Sales Breakdown by Type (2021-2026)
6.3.3 China Metronidazole Sales Breakdown by Application (2021-2026)
6.3.4 China Metronidazole Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Metronidazole Sales by Company
6.4.1.1 Japan Metronidazole Sales by Company (2021-2026)
6.4.1.2 Japan Metronidazole Revenue by Company (2021-2026)
6.4.2 Japan Metronidazole Sales Breakdown by Type (2021-2026)
6.4.3 Japan Metronidazole Sales Breakdown by Application (2021-2026)
6.4.4 Japan Metronidazole Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Metronidazole Sales by Company
6.5.1.1 India Metronidazole Sales by Company (2021-2026)
6.5.1.2 India Metronidazole Revenue by Company (2021-2026)
6.5.2 India Metronidazole Sales Breakdown by Type (2021-2026)
6.5.3 India Metronidazole Sales Breakdown by Application (2021-2026)
6.5.4 India Metronidazole Major Customers
6.5.5 India Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Hongyuan Pharmaceutical
7.1.1 Hongyuan Pharmaceutical Company Information
7.1.2 Hongyuan Pharmaceutical Business Overview
7.1.3 Hongyuan Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Hongyuan Pharmaceutical Metronidazole Products Offered
7.1.5 Hongyuan Pharmaceutical Recent Development
7.2 Yinhe Aarti Pharmaceutical
7.2.1 Yinhe Aarti Pharmaceutical Company Information
7.2.2 Yinhe Aarti Pharmaceutical Business Overview
7.2.3 Yinhe Aarti Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Yinhe Aarti Pharmaceutical Metronidazole Products Offered
7.2.5 Yinhe Aarti Pharmaceutical Recent Development
7.3 Saikang Pharmaceutical
7.3.1 Saikang Pharmaceutical Company Information
7.3.2 Saikang Pharmaceutical Business Overview
7.3.3 Saikang Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Saikang Pharmaceutical Metronidazole Products Offered
7.3.5 Saikang Pharmaceutical Recent Development
7.4 Zhongan Pharmaceutical
7.4.1 Zhongan Pharmaceutical Company Information
7.4.2 Zhongan Pharmaceutical Business Overview
7.4.3 Zhongan Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Zhongan Pharmaceutical Metronidazole Products Offered
7.4.5 Zhongan Pharmaceutical Recent Development
7.5 Wuyao Pharmaceutical
7.5.1 Wuyao Pharmaceutical Company Information
7.5.2 Wuyao Pharmaceutical Business Overview
7.5.3 Wuyao Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Wuyao Pharmaceutical Metronidazole Products Offered
7.5.5 Wuyao Pharmaceutical Recent Development
7.6 Yichang Changjiang Pharmaceutical
7.6.1 Yichang Changjiang Pharmaceutical Company Information
7.6.2 Yichang Changjiang Pharmaceutical Business Overview
7.6.3 Yichang Changjiang Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Yichang Changjiang Pharmaceutical Metronidazole Products Offered
7.6.5 Yichang Changjiang Pharmaceutical Recent Development
7.7 Tongji Pharmaceutical
7.7.1 Tongji Pharmaceutical Company Information
7.7.2 Tongji Pharmaceutical Business Overview
7.7.3 Tongji Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Tongji Pharmaceutical Metronidazole Products Offered
7.7.5 Tongji Pharmaceutical Recent Development
7.8 Hongda Pharmaceutical
7.8.1 Hongda Pharmaceutical Company Information
7.8.2 Hongda Pharmaceutical Business Overview
7.8.3 Hongda Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Hongda Pharmaceutical Metronidazole Products Offered
7.8.5 Hongda Pharmaceutical Recent Development
7.9 Topsun Pharmaceutical
7.9.1 Topsun Pharmaceutical Company Information
7.9.2 Topsun Pharmaceutical Business Overview
7.9.3 Topsun Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Topsun Pharmaceutical Metronidazole Products Offered
7.9.5 Topsun Pharmaceutical Recent Development
7.10 Unichem Laboratories
7.10.1 Unichem Laboratories Company Information
7.10.2 Unichem Laboratories Business Overview
7.10.3 Unichem Laboratories Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Unichem Laboratories Metronidazole Products Offered
7.10.5 Unichem Laboratories Recent Development
7.11 CordenPharma Farchemia
7.11.1 CordenPharma Farchemia Company Information
7.11.2 CordenPharma Farchemia Business Overview
7.11.3 CordenPharma Farchemia Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.11.4 CordenPharma Farchemia Metronidazole Products Offered
7.11.5 CordenPharma Farchemia Recent Development
7.12 API Polpharma
7.12.1 API Polpharma Company Information
7.12.2 API Polpharma Business Overview
7.12.3 API Polpharma Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.12.4 API Polpharma Metronidazole Products Offered
7.12.5 API Polpharma Recent Development
7.13 Manav Drugs
7.13.1 Manav Drugs Company Information
7.13.2 Manav Drugs Business Overview
7.13.3 Manav Drugs Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Manav Drugs Metronidazole Products Offered
7.13.5 Manav Drugs Recent Development
7.14 Aarey Drugs & Pharmaceuticals
7.14.1 Aarey Drugs & Pharmaceuticals Company Information
7.14.2 Aarey Drugs & Pharmaceuticals Business Overview
7.14.3 Aarey Drugs & Pharmaceuticals Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Aarey Drugs & Pharmaceuticals Metronidazole Products Offered
7.14.5 Aarey Drugs & Pharmaceuticals Recent Development
7.15 Aarti Drugs
7.15.1 Aarti Drugs Company Information
7.15.2 Aarti Drugs Business Overview
7.15.3 Aarti Drugs Metronidazole Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Aarti Drugs Metronidazole Products Offered
7.15.5 Aarti Drugs Recent Development
8 Metronidazole Manufacturing Cost Analysis
8.1 Metronidazole Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Metronidazole
8.4 Metronidazole Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Metronidazole Distributors List
9.3 Metronidazole Customers
10 Metronidazole Market Dynamics
10.1 Metronidazole Industry Trends
10.2 Metronidazole Market Drivers
10.3 Metronidazole Market Challenges
10.4 Metronidazole Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 123
USD 2900.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 168
USD 4900.00
(Single User License)
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 154
USD 5900.00
(Single User License)
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 123
USD 3950.00
(Single User License)
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published Date: 2025-01-16
Pages: 95
USD 2900.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-17
Pages: 179
USD 5600.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-16
Pages: 170
USD 5900.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-07
Pages: 115
USD 4900.00
(Single User License)
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 123
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 168
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 154
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 123
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published: 2025-01-16
Pages: 95
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-17
Pages: 179
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-16
Pages: 170
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-07
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now